Dantas, A. T., Gonçalves, S. M. C., de Almeida, A. R., Gonçalves, R. S. G., Sampaio, M. C. P. D., Vilar, K. d. M., . . . Pitta, M. G. d. R. (2016). Reassessing the Role of the Active TGF-β1 as a Biomarker in Systemic Sclerosis: Association of Serum Levels with Clinical Manifestations. Dis Markers.
Chicago Style CitationDantas, Andréa Tavares, et al. "Reassessing the Role of the Active TGF-β1 As a Biomarker in Systemic Sclerosis: Association of Serum Levels With Clinical Manifestations." Dis Markers 2016.
Cita MLADantas, Andréa Tavares, et al. "Reassessing the Role of the Active TGF-β1 As a Biomarker in Systemic Sclerosis: Association of Serum Levels With Clinical Manifestations." Dis Markers 2016.
Atenció: Aquestes cites poden no estar 100% correctes.